Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Secret City Vapor
WARNING LETTER
•Secret City Vapor•July 14, 2022

FDA WARNING_LETTER - Secret City Vapor - July 14, 2022

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

The FDA Center for Tobacco Products issued a Warning Letter to Secret City Vapors LLC after reviewing submissions and inspection records, determining the company manufactures and distributes e-liquid products, specifically citing Secret City Vapor POM POM 6MG 120ML e-liquid. These products are deemed tobacco products subject to FDA regulation. The FDA found that this e-liquid is a "new tobacco product" as it was not commercially marketed before February 15, 2007, and lacks the required FDA marketing authorization order under section 910(c)(1)(A)(i) of the FD&C Act. Consequently, the product is adulterated under 21 U.S.C. § 387b(6)(A) and misbranded under 21 U.S.C. § 387c(a)(6) due to the failure to provide required notice under section 905(j). The letter also highlights prohibited acts under 21 U.S.C. § 331(k) for marketing adulterated/misbranded products and 21 U.S.C. § 331(p) for failing to provide required reports. The firm, a registered manufacturer with over 700 listed products, had a Premarket Tobacco Product Application for 581 products refused acceptance. Secret City Vapors LLC must respond within 15 working days detailing corrective actions, including discontinuing violative sales and a compliance plan, to avoid further regulatory action such as civil money penalties, seizure, or injunction.

Company
Secret City Vapor
Inspection Date
July 14, 2022
Product Type
Tobacco
Office
Center for Tobacco Products
Person
  • Ann Simoneau (Director)
Open in Dashboard

ID · 2789fd48-3139-4d00-9a64-2ce485c4e751

Violation Codes10
21 U.S.C. 321(rr)21 U.S.C. 387a(b)21 CFR 1100.121 U.S.C. 387j(a)21 U.S.C. 387j(c)(1)(A)(i)21 U.S.C. 387e(j)21 U.S.C. 387e(j)(1)(A)(ii)21 U.S.C. 387e(j)(3)21 U.S.C. 387b(6)(A)21 U.S.C. 387c(a)(6)

Full citation text and observation details available on the Dashboard.

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026, Global Key Solutions All rights reserved.